BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/24/2025 6:02:30 AM | Browse: 58 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 104429
Country China
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
Manuscript Source Unsolicited Manuscript
All Author List Fei-Yu Zhao, Xiao-Ming Zhang and Nian-Song Qian
Funding Agency and Grant Number
Corresponding Author Nian-Song Qian, Chief Physician, MD, Department of Thoracic Oncology, Respiratory and Critical Care Medicine, The Eighth Medical Center of People’s Liberation Army General Hospital, No. 28 Fuxing Road, Beijing 100853, China. qianniansong1@163.com
Key Words Hepatocellular carcinoma; Bevacizumab; Lenvatinib; Sintilimab; Interventional treatment
Core Tip Interventional therapy combined with immunotherapy and targeted therapy can significantly prolong the survival of intermediate and advanced hepatocellular carcinoma, but there are very few comparative studies studying the combination of different molecular targeted drugs, different immunotherapeutic drugs, and interventional therapy. Han et al studied the efficacy of lenvatinib or bevacizumab combined with sintilimab and interventional therapy, which can help clarify the efficacy of the combination of different drugs, providing a basis for clinicians to choose the correct treatment strategy for intermediate and advanced hepatocellular carcinoma.
Citation Zhao FY, Zhang XM, Qian NS. Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy. World J Gastroenterol 2025; In press
Received
2024-12-19 15:35
Peer-Review Started
2024-12-20 01:35
To Make the First Decision
Return for Revision
2025-01-10 01:28
Revised
2025-01-13 10:06
Second Decision
2025-01-24 02:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-01-24 06:02
Articles in Press
2025-01-24 06:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com